ID2调控抗病毒天然免疫应答的机制研究
批准号:
82071795
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
黄鹤
依托单位:
学科分类:
炎症、感染与免疫
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
黄鹤
中文摘要
天然免疫是机体抗病毒感染的第一道防线。机体为清除侵入的病毒必须启动有效的天然免疫应答,为避免过度天然免疫反应导致免疫病理损伤和清除入侵的病毒后快速恢复细胞内环境稳态,宿主细胞进化出多样的机制以调控天然免疫应答的强度。对宿主抗病毒天然免疫的调控机制的研究近年来是国际上的前沿和热点研究领域。我们的前期工作证明DNA结合抑制分子2(ID2)可负向调控IRF3磷酸化并抑制I型干扰素(IFN-I)产生,但具体分子机制仍不清楚。本课题拟通过制备ID2基因缺陷细胞和条件性敲除小鼠模型,对ID2如何通过TBK1/IKKε-IRF3信号途径调控IFN-β生成的具体分子机制进行更为系统详尽的分析,在机体水平证明ID2在天然免疫应答中的负向调控作用和对2019-nCoV等病毒的复制的调控作用,以期阐明ID2负向调控抗病毒天然免疫的机制,为发现潜在的抗病毒治疗药物靶标提供新的理论基础。
英文摘要
Innate immune response is the first line of defense against viral infection. Host cells recognize viral RNA and DNA through pattern recognition receptors to activate downstream signal transduction pathways, which finally induce the production of antiviral IFN-I. In order to eliminate infected viruses, host cells must initiate effective innate immune responses, and at the same time, control the intensity of innate immune response to avoid immunopathological damage caused by overreaction, and restore homeostasis after eliminating the viruses. Therefore, host cells have evolved a complex and delicate innate immune response regulatory network. In recent years, the research on the regulation mechanism of host antiviral innate immunity is a hot spot in the field of innate immunity, but our understanding is still very limited. Our previous work has proved that ID2 can inhibit the phosphorylation of IRF3 and the production of IFN-I, but the underlying molecular mechanism is not clear. In this study, we intend to systematically and thoroughly analyze the mechanism by which ID2 regulates IFN- TBK1/IKKε-IRF3 signaling pathways, and analyze the negative regulatory role of ID2 in antiviral innate immune response in vivo. We will also investigate the regulatory role of ID2 in the replication of viruses including 2019-nCoV. The findings will expand our understanding of the innate immune regulatory network and may provide potential antiviral therapeutic targets in the future.
转录调节因子ID2在免疫细胞的发育和分化中起重要作用。有文献报道,ID2可调控I型干扰素的产生,但具体分子机制并不清楚。我们发现ID2可负调控抗病毒先天免疫反应。病毒感染人上皮细胞时,ID2结合TANK-binding kinase 1 (TBK1)和核因子κB激酶ε (IKKε)抑制剂。这些相互作用抑制TBK1或IKKε对干扰素(IFN)调节因子3 (IRF3)的募集和激活,导致IFN-β1 (IFNB1)的表达降低。IFN-β诱导ID2核输出形成负反馈回路。敲除人类细胞中的ID2增强了先天免疫反应,抑制了包括SARS-CoV-2在内的不同病毒的感染。与野生型小鼠相比,骨髓特异性ID2缺乏的小鼠对病毒感染产生更多的IFN-α,并且对病毒感染的抵抗力更强。我们的研究结果不仅确立了ID2是TBK1和/或IKKε诱导的IRF3激活的调节剂,而且还引入了先天免疫与细胞发育和分化之间的相互调控机制。
HCV通过自噬降解载脂蛋白B导致肝细胞脂质沉积的研究
-
批准号:81301440
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:黄鹤
-
依托单位:
国内基金
海外基金